Legal
Key facts
SBS is reminding investors of a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR)
Key facts
The lawsuit alleges violations of Section 10(b), Section 20(a), and SEC Rule 10b-5 under the Securities…
Key facts
The class period listed is December 17, 2025 to July 26, 2026
Atlas Watchline
Schall, Brown & Schwartz LLP says investors who bought Capricor Therapeutics shares during a listed class…